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Background: Concerns about postcessational weight gain might hamper rather than encourage smokers to quit
smoking.
Methods: We conducted a comprehensive multi-institutional smoking cessation program for health care and industrial
workers (n = 654) employed at University Hospital Basel (Switzerland) and two local health industry companies
(Novartis International AG, F. Hoffmann-La Roche AG). The program contained counselling with an option of
pharmacological support. Changes in body weight were observed during 24 months of follow-up. Factors associated
with longitudinal weight gain (>5 % of baseline weight) were identified by cox-regression analysis.
Results: In 51 % of permanent quitters no significant changes of mean body weight were observed after
12 (0.52 kg, SD ±2.87 kg) and 24 months (0.40 kg, SD ± 2.99 kg). Marked weight gain following smoking cessation
was characterized by a wide margin of changes. In more than a half of former smokers (58 %) weight increases
were moderate (<5 kg), whereas excessive increases (>10 kg) were seen in only 10 % of quitters. Lower baseline
BMI (HR 0.60, 95 % CI 0.40- 0.80, p = 0.03), daily consumption of less than ten cigarettes (HR 0.53, 95 % CI 0.27- 0.63,
p = 0.04) and ischemic cardiopathy (HR 0.21, 95 % CI 0.07-0.62; p < 0.01) were associated with a lower risk for
weight gain. Employees with lower educational levels (HR 2.60, 95 % CI 1.60-5.50, p < 0.01), diabetes mellitus
(HR 3.05, 95 % CI 2.20-8.06, p = 0.02) and those smoking to reduce boredom in life (HR 1.68, 95 % CI 1.21-2.33, p < 0.01)
were at highest risk.
Conclusion: Marked postcessational weight gain occurs less often than expected, but remains difficult to be predicted.
Our findings might be helpful to alleviate weight concerns in the average smoker willing to quit.
Keywords: Weight gain, Post- cessation, Predicting variables, Comprehensive health programBackground
Cigarette smoking is estimated to cause over five millions
deaths per year worldwide making it the leading preventable
major cause of disease and premature death with a high
burden of costs for health care systems [1, 2]. Although
smoking cessation is obviously associated with individual
health benefits, several barriers addressing physiologic and
psychosocial aspects of nicotine addiction often prevent
willingness to quit and successful smoking cessation. One of* Correspondence: scherra@uhbs.ch
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unless otherwise stated.the most important causes of failure in smoking cessation is
the fear of excessive weight gain after successful quitting
[3, 4]. In comparison with their non-smoking counterparts
a lower body weight, a deceleration of age-related weight
increase and an 80 percent probability of weight gain
occurring within 6 months after quitting is commonly
described for smokers [5–8].
Several factors have been examined to identify determi-
nants of postcessational weight gain. These include,
although partly controversially discussed, younger age
[9], female gender [10], ethnicity, low socioeconomic
status [11], baseline weight, determinants of tobacco
dependence, a sedentary lifestyle [12] and poor eatingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nicotine replacement therapy (NRT) and bupropion alone
or prescribed in combination with NRT can at least partly
prevent weight gain following smoking cessation [14–16].
Success rates of most smoking cessation interventions
remain modest, but may be increased in future through
prematurely identifying determinants of weight gain. The
main objective of the present study was to explore
postcessational weight changes in a first step and
thereafter searching for predictors of marked weight gain
in an employed population of health care and industrial
workers. For this purpose, longitudinal, prospective data




The study was designed as an investigator- initiated
and investigator- driven, open multicentre project
which aimed to implementate a comprehensive smoking
cessat-ion program in a cohort of employees. It was
conducted between May 2005 and January 2009 in Basel,
Switzerland. Smoking employees at the University
Hospital of Basel (UHBS, Basel, Switzerland) and two
local pharmaceuticals companies (Novartis Pharma AG,
Basel, F. Hofmann-La Roche AG, Basel) were recruited on
a voluntary basis from a total of 17500 employees. All
subjects were invited to take part through local advertising
such as posters, newsletters and flyers. An additional,
standardized and confidential pre-screening questionnaire
was sent to all employees of University Hospital Basel.
Returned questionnaires were analysed and smokers
interested in quitting were contacted by phone through an
occupational healthcare advisor. Main criteria of inclusion
were willingness to quit smoking, employment at one of
the three worksites, a minimum age of 17 years and a daily
consumption of at least five cigarettes. All employees
provided their written informed consent to a scientific
analysis of their data. Prior to the initiation of the
program, occupational healthcare advisors of the three
study centres received specific training in smoking
cessation counselling skills. For this, a standardized
manual of smoking cessation training for healthcare
professionals was used [18]. Aims, methodology and
study design of our smoking cessation intervention
are described more in detail elsewhere [17].
The program was designed in accordance with the
Swiss and international clinical guidelines for smoking
cessation [19, 20]. The local joint ethical committee of
the Canton of Basel, Switzerland, approved the project in
January 2005 (EKBB 34/05). Participation was on a volun-
tary basis and written informed consent for scientific
evaluation of the program was required from employees
prior to enrolment.Smoking cessation intervention
The primary intervention consisted of several in site
visits within the first 3 months following enrolment.
Each visit contained individual face-to-face counselling of
at least 15 minutes duration. Counselling support covered
standard cognitive- behavioural techniques, such as enhan-
cing motivation, highlighting health benefits, identifying
barriers, coping with cravings and relapse prevention.
Additionally pharmacological support was provided on a
voluntary basis for a total period of 3 months and followed
common recommendations of manufacturers and litera-
ture regarding dose and delivery systems [21, 22].
Employees were given the choice between either mono-
therapy or different combinations of nicotine replacement
therapy (NRT). Furthermore, bupropion could be added
to NRT or was prescribed as monotherapy [17].
After 3 months the primary intervention was com-
pleted and all employees had an in-site follow- up at 12
and 24 months, respectively. In addition, telephone
contacts asking for smoking status were provided at 6
and 18 months.
Subjects were categorized as abstinent from cigarette
smoking by asking self- reported abstinence over the last
30 days. Self-reported abstinence had to be biochemically
confirmed by an expired carbon monoxide level of less than
6 ppm measured with a Micro Smokerlyser (Bedfont, Kent,
UK). Employees who reported smoking by themselves,
had an exhaled carbon monoxide concentration equal
or greater than 6 ppb or were lost of follow- up were
categorized as relapsed smokers.
Data collection
Data were collected using a web-based standardized and
structured electronic case report form (eCRF) at all three
worksites. Clinical relevant variables were assessed at in-site
visits. Body weight (in kilograms) was measured for each
participant under control of study staff. Employees were
weighed with their clothes on, but without wearing shoes,
jackets or heavy outer garnets. Height was measured to the
nearest 0.5 cm using a tape measure without shoes using a
standardized scale. Body weight was followed up by using a
standardized spring scale at every in-site visit. The Body
mass index (BMI) was calculated as body weight (in Kg)
divided by the body height (in m2). Weight change was
calculated using baseline weight (taken at the individual
quit date at visit 3) subtracted from the body weight
measured at each consecutive visit.
Statistical analysis
Baseline characteristics of the whole population and
long- term quitters separated in those with and without
a marked weight gain following smoking cessation were
summarized with means, standard deviations (SD) or pro-
portions. Proportions and frequencies between different
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Wilcoxon-rank sum test for not normally distributed
variables. Differences in continuous variables were
analysed with the two- sample t- test, or with the
Mann- Whitney test as appropriate. Marked weight gain
was defined as an increase of more than 5 % in reference
to the baseline body weight for predictor analysis.
Absolute weight chances over times were illustrated in
kilograms including means, standard deviations and 95 %
confidence intervals. Thereby, quantitative changes of
body weight gain were categorized as excessive (more than
10 kg), severe (5–10 kg) and moderate (less than 5 kg) for
descriptive statistics (see section results). Longitudinal
weight analysis was carried out separately for the whole
study population, part- time quitters (abstainers for at
least two consecutive visits) and those who remained
permanently (over 24 months) abstinent.
In order to detect the effect of nicotine abstinence
(versus non- abstinence) on body weight, linear mixed
effect models were created. An uni- and multivariable
cox- regression analysis to predict the risk of marked
weight increase was calculated for several variables of
clinical interest. Results are presented as hazard ratios
(HR) and 95 % confidence intervals with corresponding
p-values. For continuous or ordinal variables hazard ratios
had to be based on a meaningful difference of the
predicting variable. They were expressed as the ratio
from the odds from the 3rd to the 1st quartile representing
a typical above average to a typical below average value.
All models were adjusted by age, gender and other
confounding variables. Due to the exploratory character of
the study, no adjustments for multiple comparisons were
done. The method for selection of a best subset of
variables was based on a stepwise procedure by
Akaike Information Criterion (AIC). AIC is a measure
of quality of statistical models. Variables were deleted from
the whole model until the value of the AIC signifi-
cantly increased, as previously described [23]. Harrel’s
concordance index (C-Index) was calculated with cor-
responding 95 % confidence intervals to evaluate the
concordance between predicted and observed weight gain.
All analysis were done using R version 3.0.1. [24].
Results
Postcessational weight gain
Assuming a smoking prevalence of about 25 % in the
overall swiss population, at least 4250 employees from a
total of 17500 employees at the three study centres were
estimated to be active smokers [25, 26]. Within our
program an estimated 20 % or 885 smoking employees
could be recruited initially to quit smoking. 2,555 out of
4449 (57 %) pre-screening questionnaires were returned
from employees of University Hospital of Basel. 1,455
(57 %) employees were categorized as non-smokers, 791employees (31 %) as former smokers and 333 employees
(13 %) as active smokers. 253 (76 %) out of 333 active
smokers were eligible for enrolment and signed the
informed consent. Furthermore, 344 smokers out of 9000
employees and 288 smokers out of 4000 employees
entered the program from the worksites F. Hoffman- La
Roche AG (Basel, Switzerland) and Novartis Pharma AG
(Basel, Switzerland) respectively. Participation rates of
recruited smokers were in both centres about 70 %.
During the follow-up phase three study subcentres
had to be closed due to internal restructuring of the two
health companies leading to exclusion of 182 employees.
49 further cases had to be excluded due to missing weight
data at several time points in 24, invalid data entries in 3
and missing of relevant covariates in 22 cases. Finally,
data from 654 employees were eligible for postcessational
weight analysis.
The study population consisted of slightly more male,
mid-aged smokers with an average consumption of
11–20 cigarettes day and moderate to severe nicotine
dependence on FTND. Descriptive characteristics at
baseline for the whole study population and separately
illustrated for long-term quitters with or without a 5 %
increase of body weight are depicted in Table 1. There
were no significant baseline differences of demographic
data, prevalence of comorbidities, smoking related vari-
ables and different types of pharmacological cessation
support with the exception of a slightly lower prevalence
of heart disease and higher values of FTND in quitters
with marked weight gain. At 24 months of follow- up, 229
employees (35 %) from 654 employees were continuously
abstinent. 268 employees (41 %) were categorized as lost-
of follow- up. 156 employees (24 %), who were categorized
as ongoing smokers or not permanent quitters absolved
the whole follow-up of 24 months.
Mean weight gain over time in the whole study popula-
tion (n = 654) was 0.80 kg (±1.20 kg) at 1 month, 1.84 kg
(±1.50 kg) at 3 months, 2.04 kg (±1.90 kg) at 12 months
and 1.98 kg (±2.20 kg) after 24 months, respectively. At
the time of 12 and 24 months, weight changes from
permanent abstainers were significantly different from
baseline as compared with relapsed smokers (p < 0.01).
Weight differences over time splitted for abstinence vs.
non- abstinence are illustrated in Fig. 1.
In about a half of permanent quitters (n = 114, 49 %)
marked weight gain occurred. Average longitudinal
increase of body weight in these 114 subjects was
1.30 kg (SD ±2.40 kg) at 1 month, 2.90 kg (SD ±2.91 kg)
at 3 months, 5.07 kg (SD ±3.50 kg) after 1 year and
remained stable thereafter with 5.15 kg (±4.14 kg) at
2 year follow-up (p < 0.01). Excessive weight gain (>10 kg)
occurred in 11 (10 %), severe (5–10 kg) in 36 (32 %) and
moderate gain (less than 5 kg) in 67 (58 %) out of 114 per-
manent quitters. By comparison, in 51 % of long-term
Table 1 Baseline characteristics of employees participating in a smoking cessation program
Characteristics All subjects (n = 654) Long-term quitters (n = 229)
Demographics Subjects without increase of
body weight >5 % (n = 115)
Subjects with Increase of
body weight >5 % (n = 114)
p-value
Age, years a 42.4 (±9.7) 43.4 (±9.7) 44.2 (±9.31) 0.53
Gender b 0.64
Male 369 (56) 61 (53) 65 (57)
female 285(44) 54 (47) 49(43)
Height, cm c 173 (167–180) 173 (168–180) 173 (167–180) 0.76
Weight, kg c 75.6 (64–84) 74.8 (64–83) 74.6 (65–84) 0.45
BMI a 25.1(±4.00) 25.1 (±4.23) 25.4 (±4.44) 0.52
Civil status b 0.47
single 218 (33) 36 (31) 35 (31)
married 330 (51) 57 (50) 61 (53)
divorced 95 (14) 19 (16) 18(16)
widowed 11 (2) 3 (3) 0 (0)
Education b 0.56
University 141 (22) 35 (31) 28 (25)
Apprenticeship 466 (72) 73 (64) 77 (68)
Basic education 41 (6) 6 (5) 8 (7)
Comorbidities b
Arterial hypertension 37 (6) 9 (8) 13 (7) 1.00
Coronary heart disease 28 (4) 11 (10) 2 (2) 0.02
Diabetes mellitus 16 (2) 12 (11) 13 (11) 1.00
Malignancy 27 (4) 5 (4) 4 (4) 1.00
Epilepsy 15 (2) 5 (4) 2 (2) 0.45
Psychiatric disorder 91 (14) 24 (21) 13 (11) 0.08
Antidepressant medication 112 (17) 23 (20) 16 (14) 0.31
Satisfaction with Life Scale (Qol), points c 26 (24–30) 27 (25–31) 26 (23–30) 0.82
Respiratory symptoms b
Cough 253 (39) 34 (30) 38 (34) 0.61
Sputum 176 (27) 25 (22) 26 (23) 0.97
Wheezing 124 (19) 26 (23) 17 (15) 0.19
Breathlessness at rest 44 (7) 12 (10) 10 (9) 0.84
Breathlessness on exertion 288 (44) 47 (41) 45 (39) 0.94
Smoking-related history
Age at starting smoking, years a 17 (±3.7) 17 (±3.8) 17 (±3.5) 1.00
Prior attempts to quit a 3.0 (±3.5) 2.9 (±3.3) 3.1 (±3.8) 0.78
Duration longest nicotine abstinence, months a 20 (±51) 21 (±45) 20 (±54) 0.69
Years, smoked a 22 (±8.5) 21 (±10.3) 22 (±8.5) 0.85
Number of cigarettes/day b 0.29
0-10 82 (13) 22 (19) 12 (11)
11-20 329 (50) 59 (51) 67 (59)
21-30 184 (28) 28 (24) 27 (24)
>30 58 (9) 6 (5) 8 (7)
FTND, points a 4.5 (±2.40) 3.7 (±2.40) 4.5 (±2.30) 0.02
Intensity of craving, (VAS 0–100) a 57 (±32) 58 (±32) 55 (±21) 0.09
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Table 1 Baseline characteristics of employees participating in a smoking cessation program (Continued)
Exhaled CO, ppm a 22.6 (±14.7) 20.2 (±15.1) 22.0 (±13.9) 0.38
Pharmacological support 0.91
NRT
Mono 82 (13) 12 (10) 11 (10)
Combined 124 (19) 24 (22) 21 (19)
Mono + Bupropion 92 (14) 12 (10) 13 (12)
Combined + Bupropion 265 (42) 52 (45) 57 (50)
Bupropion 42 (6) 5 (4) 5 (4)
Counselling only 47 (6) 10 (9) 6 (5)
Data are illustrated for all subjects and permanent abstainers with and without significant change in body weight gain (def. Increase of body weight > 5 % as
compared to baseline within 2-years)
a Values are means ± SD, b absolute numbers (%) or c medians with interquartile ranges, BMI = Body mass index; FTND = Fagerstroem test for nicotine
dependence, exhaled CO = exhaled carbon monoxide; NRT = Nicotine replacement therapy
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weight were observed [0.07 kg (±1.69 kg) at 1 month, 0.68
(±2.23 kg) at 3 months, 0.52 kg (±2.87 kg) at 12 months
and 0.40 kg (±2.99 kg)] after 24 months. The risk of
smoking relapse was significantly lower for smokers
with an weight gain between 0 and 10 kg as com-
pared to the subgroup with excessive weight gain
(>15 kg) ( HR 0.32; 95 % CI 0.25-0.42, p < 0.01).
Predictors of postcessational weight gain
Univariate- and multivariate Cox regression analysis
assessing characteristics potentially associated with marked
weight gain (defined as 5 % increase of baseline weight)
after smoking cessation are summarized in Table 2. Taken
demo-graphic characteristics into account, only a lower
baseline weight (BMI 20 vs. 30) was associated with a
lower chance of postcessational weight gain (HR 0.60,Fig. 1 Longitudinal effect of nicotine abstinence on weight changes as co
significant increased after 12 months as compared to relapsed smokers (n =95 % CI 0.40-0.80, p = 0.03). In contrast to univariate
analysis (HR 1.42, 95 % CI 1.07-1.87, p = 0.01), female gen-
der was not an independent predictor for marked weight
gain on multivariate analysis (HR 1.40, 95 % CI 0.93-
2.10, p = 0.11). Similarly, age of employees (30 vs. 50 years)
was also not predictive for weight gain (HR 1.00, 95 % CI
0.97-1.03, p = 0.94). In contrast, a lower level of education,
namely basic education or apprenticeship, were strongly
associated with an increase of body weight (basic edu-
cation HR 2.90 95 % CI 1.39-4.83, p < 0.01, appren-
ticeship HR 2.60, 95 % CI 1.60-5.50, p < 0.01). From
present comorbidities a concomitant diagnosis of dia-
betes mellitus or ischemic cardiopathy was found to
be independently associated with weight changes.
Thereby, diabetes mellitus was a strong risk factor (HR
3.05, 95 % CI 2.20-8.06, p = 0.02), whereas employees with
coronary disease seemed to have a lower risk for weightmpared to baseline. Postcessational weight gain of quitters was
654)
Table 2 Univariate and multivariate cox- regression analysis to predict postcessational weight gain of more than 5 % of baseline
body weight within 24 months (n = 654)
n = 654 Univariate cox -regression analysis Multivariate cox-regression analysis
Variables HR 95 % CI p HR 95 % CI p
Demographics
Age (30 vs. 50 years) 1.00 0.99-1.02 0.59 1.00 0.97-1.03 0.94
BMI (20 vs. 30) 0.45 0.35-0.85 0.02 0.60 0.40-0.80 0.03
Gender
Male —— —— —— — — —
Female 1.42 1.07-1.87 0.01 1.40 0.93-2.10 0.11
Civil status
Single) —— —— —— — — —
Married 0.97 0.64-1.46 0.88 — — —
Divorced 0.78 0.44-1.39 0.46 — — —
Widowed 1.40 0.46-4.17 0.55 — — —
Education
University —— —— —— — — —
Apprenticeship 1.97 1.20-3.24 <0.01 2.60 1.60-5.50 <0.01
Basic education 3.02 1.60-5.36 <0.01 2.90 1.39-4.83 <0.01
Comorbidities
Arterial Hypertension 0.99 0.52-1.91 1.00 1.05 0.51-2.18 0.89
Coronary heart disease 0.34 0.12-0.95 0.02 0.21 0.07-0.62 <0.01
Diabetes mellitus 2.22 1.11-6.01 0.04 3.05 2.20-8.06 0.02
Malignancy 1.01 0.44-2.32 0.98 0.61 0.25-1.50 0.28
Epilepsy 1.08 0.78-1.86 0.78 1.42 0.5-1.32 0.45
Antidepressant medication 0.93 0.62-1.40 0.73 0.89 0.54-1.46 0.64
Psychiatric disorder 1.19 0.78-1.80 0.41 1.07 0.62-1.85 0.79
Satisfaction with Life (Qol), (points) 0.98 0.95-1.01 0.26 0.98 0.95-1.02 0.42
Respiratory Symptoms
Cough 1.02 0.99-1.04 0.18 1.00 0.90-1.08 0.42
Sputum 1.50 1.08-2.07 0.01 1.32 0.89-1.95 0.17
Wheezing 1.23 1.10-2.34 0.26 1.31 1.09-1.17 0.35
Breathlessness at rest 1.59 0.94-2.69 0.09 1.29 0.65-2.55 0.47
Breathlessness at exertion 1.04 0.78-1.37 0.80 0.93 0.66-1.30 0.66
Smoking related history
Number of cigarettes/day
0-10 0.56 0.34-0.93 0.02 0.53 0.27-0.63 0.04
21-30 0.90 0.64-1.27 0.55 0.74 0.48-1.14 0.18
>30 1.34 0.81-2.20 0.25 0.97 0.48-1.96 0.94
FTND (6 vs. 3 points) 1.09 1.03-1.16 0.01 1.09 0.98-1.21 0.12
Intensity of craving (VAS 100 vs. 50) 1.00 0.99-1.01 0.35 1.00 0.99-1.00 0.50
Exhaled CO, ppb 1.07 0.99-1.02 0.11 0.99 0.99-1.01 0.84
Motivation to quit (VAS 100 vs.50) 1.00 0.99-1.01 0.48 1.00 0.99-1.02 0.63
Motivation for smoking
Weight control 1.10 0.79-1.55 0.57 1.02 0.65-1.59 0.94
Dependency 0.91 0.60-1.38 0.66 0.91 0.61-1.38 0.66
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Table 2 Univariate and multivariate cox- regression analysis to predict postcessational weight gain of more than 5 % of baseline
body weight within 24 months (n = 654) (Continued)
Mood control 1.32 0.93-1.86 0.12 0.97 0.63-1.48 0.87
Boredom 1.50 1.13-1.99 <0.01 1.68 1.21-2.33 <0.01
Unwillingness to quit 1.40 1.02-1.92 0.04 1.25 0.84-1.84 0.27
Relaxation 1.02 0.76-1.36 0.92 0.90 0.62-1.31 0.60
Obstipation 1.12 0.70-1.78 0.64 0.92 0.49-1.71 0.79
Pharmacological support
Counselling only —— —— —— — —
NRT
Mono 0.82 0.41-1.68 0.59 — — —
Combined 1.09 0.57-2.1 0.80 — — —
Mono + bupropion 0.99 0.50-1.97 0.98 — — —
Combined + bupropion 1.75 0.95-3.19 0.07 — — —
Bupropion 1.43 0.68-3.02 0.34 — — —
The reference category for discontinuous or ordinal variables is given in parentheses. For continuous or ordinal variables, OR had to be based on meaningful
differences of the predicting variable. BMI = Body mass index; FTND = Fagerstroem test for nicotine dependence; exhaled CO = exhaled carbon monoxide;
NRT = Nicotine replacement therapy
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variables of nicotine dependency, namely FTND or Craving
scores, revealed no differences in weight changes, although
at least a daily consumption of less than ten cigarettes per
day appeared to be protective for excessive weight gain
(HR 0.53, 95 % CI 0.27-0.63, p = 0.04). The association of
cigarette smoking to reduce feelings of boredom resulted
in significant higher body weight after quitting (HR 1.68,
95 % CI 1.21-2.33, p < 0.01).
Differences in weight gain could not be observed
when different types of nicotine replacement therapy
with or without bupropion were assessed individually
in comparison with the counselling only option. A total of
9 variables were selected for a best subset regression
model and a nomogram to estimate one and two year
probability for marked weight gain was constructed
(c- index. 0.68, 95 % CI [0.63; 0.72]) (see Fig. 2).
Discussion
To our knowledge, the present study is one of the first
of its kind to examine long-term weight gain in order to
identify predicting factors in a cohort of healthy mid-aged
workers participating in a comprehensive worksite related
health intervention.
As a main finding of the present study, we observed
no significant weight changes following smoking ces-
sation in more than a half of long-term quitters. In
the subgroup of long-term with marked weight gain
we revealed a mean weight increase of 5 kg after
quitting with a high variability between individuals. We
were also able to identify some determinants which
are potentially useful to prematurely identify smokers
at greatest risk.The relationship between smoking cessation and
consecutive weight gain is considered to be complex
in nature and most likely multifactorially conditioned.
In line with previous research, smoking cessation was
clearly associated with substantial weight gain in many
smokers of our population. Thereby it should be mentioned
that the frequency, the amount and pattern of weight gain
differed widely between investigated populations in the past
[27, 28]. In general, assessment of postcessational weight
changes is made complex by several facts. The majority of
healthy adults in developed countries tend to gain weight
with age as it has be shown in several large population
studies [10, 29]. More recent data have also confirmed this
observation in a smoking population [30]. Furthermore, the
individual body weight might also be relevant influenced by
different cultural and nutritionals factors [31, 32]. In
addition, studies in homozygotic twins have demonstrated
that the postcessational weight gain might be in large a part
of compensation for underweight in the smoking twin
compared to the non-smoking twin [33]. Therefore, a
genetic component of individual body weight might
also affect postcessational weight gain.
Finally, contrary reports about weight gain following
smoking cessation could also be explained –at least
to some extent- by several methodological reasons
including the use of only self- reported height and
weight, failure to biochemically confirm smoking sta-
tus, missing control- groups, using more often point-
versus continuous abstinence and limited follow-up
periods [34].
Relevant weight gain might both negatively affect the
outcome of a quit attempt and at least party attenuate the
health benefits of smoking cessation due to an increased
Fig. 2 “Best subset regression” model for weight gain predicting variables. To use the nomogram, locate the first variable. Draw line straight up to the
points axis to determine the number of points received for the variable. This has to be repeated for all other variables and points achieved for each
variable have to be summarized. The sum of these numbers is located on the total point axis and a line drawn has to be drawn down to determine
the likehood of 1- and 2- probability of postcessational weight gain. BMI = Body Mass Index, FTND= Fagerstroem Test for Nicotine Dependence
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high-risk subjects [35, 36].
We found a mean weight gain of 5 kg occurring in the
first year after quitting, which is in line with various earlier
reports describing an increase between 4 to 6 kilograms
occurring within the first year in continuously abstinent
outpatient smokers [4, 37–40]. As one might expect, we
observed greater weight gain over time in permanent
abstainers as compared to non-sustained quitters and
ongoing smokers. Significant gain of body weight occurred
mostly within the first year post quitting and showed
thereafter a tendency to stabilize until 24 months.
Although evidence whether weight increase beyond one
year continues is conflicting, our observation stands in
agreement with some newer investigations [41–43].
Some randomized clinical studies postulated that both
NRT and bupropion might prevent or at least attenuate
weight gain [39, 44, 45]. However, other investigations
could not confirm this finding [40, 46]. In the present
study, we found no differences in weight changes post-
quitting in regards to several modalities of nicotine
replacement with or without bupropion as comparedto counselling advice only. Nevertheless, it should be men-
tioned, that our finding was made in a non- randomized,
“real-life” setting with unmatched treatment groups. The
non-effect of NRT on weight might be therefore due to a
self-selection of NRT by heavier smokers with an overall
higher risk for weight gain. Furthermore, we did not
provide pharmacological support with varenicline, which
might be more effective in attenuating weight gain than
NRT based on latest findings [47].
Postcessational weight gain is considered both to
negatively affect the outcome of a quit attempt and at
least party attenuate the health benefits of smoking
cessation due to an increased probability for metabolic
and cardio-vascular disorders in high- risk subjects [35, 36].
Data from the present study showed that smokers with
excessive postcessational weight gain (>10 kg) had a
significant higher rate of smoking relapse. Therefore,
meaningful predictor variables would be helpful to
identify smokers at risk for postcessational weight gain.
Predictors identified by existing reports have a number of
limitations including restricted generality (data were often
collected in clinical populations), which probably differ in
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smokers [48–51]. In addition, results of population-based
investigations often relied on retrospective reports without
any objective assessment of weight and smoking status.
Additionally, long-term success rates of cessation inter-
ventions remained often low. In the present study weight
increases revealed a broad range of variation with
moderate weight gain (<5 kg) in 58 % and excessive
weight gain (>10 kg) in only 10 % of former smokers
respectively [11, 37]. Therefore many tested predictor
variables for a 5 % increase of baseline weight might
be therefore inaccurate in the individual case.
A lower educational level was the strongest risk factors
for weight gain after quitting in the present study. Although
data describing the influence of socioeconomic variables
on body weight gain are scarce, adopted health habits
including limited resources for changing nutritional
intake and a more sedentary lifestyle in less educated
smokers may contribute to relevant weight gain following
smoking cessation [11]. Addressing motivational factors,
employees who reported to smoke for reducing boredom
in their life were significant more vulnerable for weight
increase. This may represent an increased caloric intake as
vicarious satisfaction. In contrast, employees who reported
to utilize smoking as weight control practice had surpris-
ingly neither an increased risk to gain weight after smok-
ing cessation nor lower abstinence rates, although this
subgroup of smokers was associated with higher nicotine
dependence and lower resources of self- efficacy to
control body weight [52]. This observation can’t be fully
explained, because data about important confounding
variables like restraint eating or increased physical activities
during quit attempts were not collected in the present
study. Furthermore, the association between individual
weight concerns and weight gain after cessation remains
controversially discussed in literature [53, 54].
The subgroup of subjects suffering from diabetes had a
greater change for weight gain. This seems to be particu-
larly relevant due to the potentially elevated risk for
uncontrolled metabolic situation, morbidity and mortality
following smoking cessation [55, 56].
The lower risk of weight gain in subjects with coronary
heart disease seems surprising at first glance. We assume
that employable subjects with coronary heart disease
might display a higher alertness for healthier lifestyles. We
didn’t found any related articles in order to scientifically
substantiate this observation. Additionally, the sample size
participants with coronary heart disease (n = 28) was quite
low, so the strength of this observation needs further
proof due to a low statistical power.
In accordance with previous investigations, smokers
with a lower amount of cigarettes smoked per day at
baseline seem to be less vulnerable for weight gain
suggesting that lower levels of nicotine dependencemay be protective against body weight increase [40, 57].
Importantly, it should be mentioned, that our population
consisted mainly of low and medium dependent smokers
(FTND mean: 4.42 pts, SD ±2.30) and therefore other
determinants of nicotine dependence, namely FTND,
carbon monoxide and intensity of craving might have failed
to independently predict weight gain. The observation, that
individual characteristics like age and gender showed no
association with postcessational weight gain are in line
with some, but not all earlier reports [11, 12, 58, 59]. Our
findings are also in accordance with some earlier investi-
gations showing that smokers with normal baseline BMI
(20 kg/m2) are less vulnerable for marked gain than those
with higher baseline weight (BMI 30 kg/m2) [58, 60].
The present study has some strengths and limitations.
The strengths consist of its community based approach
and a high rate of successful long-term quitters (over 35 %
at 24 months). In line with a more recent published study
we also analysed weight changes for continuous abstainers,
part-time quitters and ongoing smokers at different points
of time through a longitudinal model [40]. The later aspect
ensured that weight changes of all participants were taken
into account and not only weight changes from those who
remained permanently abstinent or completed the whole
follow-up.
One of our most important limitations is the absence of a
control group of lifelong non- smokers that would certainly
have added to the strength of the study. Nevertheless, in
contrast to many similar studies a relevant number of 156
unsuccessful smokers was followed up for 24 months.
These participants represented a kind of internal control
group enabling us to better estimate the impact of per-
manent smoking cessation on long-term body weight.
In summary marked weight gain following smoking
cessation occurred in less than a half of smokers following
smoking cessation. The majority of smokers intending to
quit smoking has concerns about postcessational weight
gain and the experience of a minority of quitters who gain
large amounts of weight may discourage them from
quitting. Therefore, it seems important that health care
providers alleviate weight concerns and encourage
smokers for a quit attempt. Numerous demographic,
socioeconomic, smoking related, cultural and even genetic
factors were associated with postcessational weight gain.
Therefore, it seems improbable that a single or even a
subset of variables as demonstrated by the moderate
performance of our multidimensional model can predict
individual weight gain following smoking cessation.
Nevertheless, early recognition of those smokers at risk
for excessive weight gain could enhance the success
rate of smoking cessation interventions. Further longitu-
dinal well- designed studies are needed to further
characterize the determinants of smokers who are particu-
larly vulnerable for weight gain.
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The present study is one of the first of its kind investigat-
ing postcessational weight changes in a large community
of health care and industrial workers participating on a
comprehensive smoking cessation intervention. One of
the main findings of our investigation is the observation
that marked weight gain following smoking cessation
occurs less often than expected. Consistent with previous
reports, long- term abstinence was associated with a mean
weight gain of 5 kilograms, which occurred in continuous
quitters within 1 year. Although some determinants of
weight gain could be identified, accurate prediction
using a clinical set of characteristics remains difficult
in the individual case.
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